nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CYP3A7—Temsirolimus—kidney cancer	0.113	0.117	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.113	0.117	CbGbCtD
Levomethadyl Acetate—CYP19A1—Paclitaxel—kidney cancer	0.0895	0.0924	CbGbCtD
Levomethadyl Acetate—CYP3A5—Temsirolimus—kidney cancer	0.0847	0.0875	CbGbCtD
Levomethadyl Acetate—CYP3A4—Everolimus—kidney cancer	0.0489	0.0505	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0388	0.04	CbGbCtD
Levomethadyl Acetate—CYP3A7—Paclitaxel—kidney cancer	0.0388	0.04	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0344	0.0355	CbGbCtD
Levomethadyl Acetate—CYP3A7—Sorafenib—kidney cancer	0.0344	0.0355	CbGbCtD
Levomethadyl Acetate—CYP3A7—Vincristine—kidney cancer	0.0334	0.0345	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0334	0.0345	CbGbCtD
Levomethadyl Acetate—CYP3A4—Temsirolimus—kidney cancer	0.033	0.0341	CbGbCtD
Levomethadyl Acetate—CYP3A5—Erlotinib—kidney cancer	0.0318	0.0328	CbGbCtD
Levomethadyl Acetate—CYP3A5—Paclitaxel—kidney cancer	0.0291	0.03	CbGbCtD
Levomethadyl Acetate—CYP3A7—Sunitinib—kidney cancer	0.0279	0.0288	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0279	0.0288	CbGbCtD
Levomethadyl Acetate—CYP3A5—Sorafenib—kidney cancer	0.0258	0.0267	CbGbCtD
Levomethadyl Acetate—CYP3A5—Vincristine—kidney cancer	0.0251	0.0259	CbGbCtD
Levomethadyl Acetate—CYP3A5—Sunitinib—kidney cancer	0.0209	0.0216	CbGbCtD
Levomethadyl Acetate—CYP3A4—Pazopanib—kidney cancer	0.0174	0.0179	CbGbCtD
Levomethadyl Acetate—CYP3A4—Erlotinib—kidney cancer	0.0124	0.0128	CbGbCtD
Levomethadyl Acetate—CYP3A4—Paclitaxel—kidney cancer	0.0113	0.0117	CbGbCtD
Levomethadyl Acetate—CYP3A4—Sorafenib—kidney cancer	0.0101	0.0104	CbGbCtD
Levomethadyl Acetate—CYP3A4—Vinblastine—kidney cancer	0.00995	0.0103	CbGbCtD
Levomethadyl Acetate—CYP3A4—Vincristine—kidney cancer	0.00978	0.0101	CbGbCtD
Levomethadyl Acetate—CYP3A4—Sunitinib—kidney cancer	0.00816	0.00842	CbGbCtD
Levomethadyl Acetate—CYP3A4—Doxorubicin—kidney cancer	0.00611	0.00631	CbGbCtD
Levomethadyl Acetate—Loperamide—POMC—kidney cancer	0.00108	0.582	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—PTGS1—kidney cancer	0.000194	0.105	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP1A1—kidney cancer	0.000173	0.0937	CrCbGaD
Levomethadyl Acetate—Loperamide—ABCB1—kidney cancer	0.000128	0.0694	CrCbGaD
Levomethadyl Acetate—Promethazine—ABCB1—kidney cancer	9.26e-05	0.0502	CrCbGaD
Levomethadyl Acetate—Tamoxifen—ABCB1—kidney cancer	9.2e-05	0.0498	CrCbGaD
Levomethadyl Acetate—Methadone—ABCB1—kidney cancer	9.12e-05	0.0494	CrCbGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ACY1—kidney cancer	5.17e-05	0.00177	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK3—kidney cancer	5.08e-05	0.00174	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.08e-05	0.00174	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PDHB—kidney cancer	5.06e-05	0.00174	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—POMC—kidney cancer	5.05e-05	0.00173	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—OR4C13—kidney cancer	5.03e-05	0.00172	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.99e-05	0.00171	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—ANXA1—kidney cancer	4.91e-05	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTP1—kidney cancer	4.88e-05	0.00167	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK1—kidney cancer	4.84e-05	0.00166	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	4.81e-05	0.00165	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CCBL1—kidney cancer	4.76e-05	0.00163	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—kidney cancer	4.71e-05	0.00161	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.59e-05	0.00157	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.53e-05	0.00155	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	4.51e-05	0.00155	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTM1—kidney cancer	4.48e-05	0.00154	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	4.42e-05	0.00152	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PDHB—kidney cancer	4.4e-05	0.00151	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—POMC—kidney cancer	4.38e-05	0.0015	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.3e-05	0.00148	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LATS1—kidney cancer	4.27e-05	0.00147	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	4.25e-05	0.00146	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	4.19e-05	0.00144	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—MAPK1—kidney cancer	4.18e-05	0.00143	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CCBL1—kidney cancer	4.13e-05	0.00142	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPAT—kidney cancer	4.13e-05	0.00142	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GLIPR1—kidney cancer	4.13e-05	0.00142	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.07e-05	0.0014	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	4.04e-05	0.00138	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.03e-05	0.00138	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	4.03e-05	0.00138	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	4e-05	0.00137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—kidney cancer	3.97e-05	0.00136	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	3.9e-05	0.00134	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—AKAP13—kidney cancer	3.89e-05	0.00133	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—APRT—kidney cancer	3.84e-05	0.00132	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—FH—kidney cancer	3.84e-05	0.00132	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—MAPK1—kidney cancer	3.82e-05	0.00131	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.75e-05	0.00129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ACY1—kidney cancer	3.74e-05	0.00128	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.72e-05	0.00128	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AMER1—kidney cancer	3.63e-05	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GPC3—kidney cancer	3.61e-05	0.00124	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GLIPR1—kidney cancer	3.58e-05	0.00123	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPAT—kidney cancer	3.58e-05	0.00123	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—AKAP13—kidney cancer	3.53e-05	0.00121	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	3.52e-05	0.00121	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CA2—kidney cancer	3.51e-05	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.42e-05	0.00117	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ALAD—kidney cancer	3.42e-05	0.00117	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ST3GAL2—kidney cancer	3.34e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—FH—kidney cancer	3.33e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—APRT—kidney cancer	3.33e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ITPR2—kidney cancer	3.31e-05	0.00113	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.27e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ALDH1A1—kidney cancer	3.26e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	3.24e-05	0.00111	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PDHB—kidney cancer	3.18e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—POMC—kidney cancer	3.17e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	3.17e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.16e-05	0.00108	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GPC3—kidney cancer	3.13e-05	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PGK1—kidney cancer	3.13e-05	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC5A3—kidney cancer	3.13e-05	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—LDHB—kidney cancer	3.07e-05	0.00105	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.07e-05	0.00105	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CA2—kidney cancer	3.05e-05	0.00104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GPC3—kidney cancer	3.05e-05	0.00104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CER1—kidney cancer	3.05e-05	0.00104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ITPR2—kidney cancer	3e-05	0.00103	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	2.99e-05	0.00103	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CCBL1—kidney cancer	2.99e-05	0.00102	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ALAD—kidney cancer	2.97e-05	0.00102	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ST3GAL2—kidney cancer	2.9e-05	0.000994	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ALDH1A1—kidney cancer	2.83e-05	0.000971	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.77e-05	0.000951	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ANXA1—kidney cancer	2.77e-05	0.000951	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PGK1—kidney cancer	2.72e-05	0.000931	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC5A3—kidney cancer	2.72e-05	0.000931	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—LDHB—kidney cancer	2.66e-05	0.000913	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CA9—kidney cancer	2.66e-05	0.000912	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	2.66e-05	0.000912	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.6e-05	0.000891	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.59e-05	0.000888	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPAT—kidney cancer	2.59e-05	0.000888	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SFRP2—kidney cancer	2.59e-05	0.000888	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ANXA1—kidney cancer	2.52e-05	0.000863	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—FH—kidney cancer	2.41e-05	0.000826	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—APRT—kidney cancer	2.41e-05	0.000826	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—POMC—kidney cancer	2.4e-05	0.000824	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CA9—kidney cancer	2.31e-05	0.000792	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.27e-05	0.000777	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GPC3—kidney cancer	2.26e-05	0.000776	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CRABP1—kidney cancer	2.26e-05	0.000775	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.24e-05	0.000767	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CA2—kidney cancer	2.2e-05	0.000755	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ALAD—kidney cancer	2.15e-05	0.000736	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ITPR2—kidney cancer	2.1e-05	0.000721	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.09e-05	0.000718	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKAP13—kidney cancer	2.09e-05	0.000716	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP2—kidney cancer	2.09e-05	0.000716	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.08e-05	0.000714	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.05e-05	0.000705	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.05e-05	0.000702	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.98e-05	0.000677	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CRABP1—kidney cancer	1.96e-05	0.000673	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.96e-05	0.000673	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PGK1—kidney cancer	1.96e-05	0.000673	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.95e-05	0.000668	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.94e-05	0.000664	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—LDHB—kidney cancer	1.93e-05	0.00066	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTT1—kidney cancer	1.92e-05	0.000657	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ACHE—kidney cancer	1.92e-05	0.000657	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GRB7—kidney cancer	1.91e-05	0.000655	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ITPR2—kidney cancer	1.83e-05	0.000626	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000622	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS1—kidney cancer	1.8e-05	0.000616	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ITPR2—kidney cancer	1.77e-05	0.000609	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PSMD7—kidney cancer	1.76e-05	0.000604	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACY1—kidney cancer	1.74e-05	0.000596	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—BCHE—kidney cancer	1.67e-05	0.000573	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CA9—kidney cancer	1.67e-05	0.000572	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTT1—kidney cancer	1.66e-05	0.000571	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ACHE—kidney cancer	1.66e-05	0.000571	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC5A5—kidney cancer	1.65e-05	0.000566	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	1.61e-05	0.000552	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HSPB1—kidney cancer	1.6e-05	0.000549	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	1.6e-05	0.000549	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000546	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SCARB1—kidney cancer	1.58e-05	0.00054	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS1—kidney cancer	1.56e-05	0.000535	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.55e-05	0.00053	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PSMD7—kidney cancer	1.53e-05	0.000525	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSC1—kidney cancer	1.49e-05	0.00051	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ANXA1—kidney cancer	1.49e-05	0.00051	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PSMD7—kidney cancer	1.49e-05	0.00051	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PDHB—kidney cancer	1.48e-05	0.000507	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—POMC—kidney cancer	1.47e-05	0.000505	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—BCHE—kidney cancer	1.45e-05	0.000497	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FLT1—kidney cancer	1.44e-05	0.000494	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.43e-05	0.000491	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CRABP1—kidney cancer	1.42e-05	0.000487	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CCBL1—kidney cancer	1.39e-05	0.000476	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.38e-05	0.000474	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—POMC—kidney cancer	1.36e-05	0.000466	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.35e-05	0.000462	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PAK1—kidney cancer	1.34e-05	0.000458	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—JUNB—kidney cancer	1.34e-05	0.000458	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTP1—kidney cancer	1.33e-05	0.000456	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ITPR2—kidney cancer	1.32e-05	0.000452	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ABCB1—kidney cancer	1.26e-05	0.000431	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—POMC—kidney cancer	1.23e-05	0.000423	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTM1—kidney cancer	1.22e-05	0.000419	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPAT—kidney cancer	1.2e-05	0.000413	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.2e-05	0.000413	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ACHE—kidney cancer	1.2e-05	0.000413	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTT1—kidney cancer	1.2e-05	0.000413	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP1A1—kidney cancer	1.16e-05	0.000397	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—kidney cancer	1.15e-05	0.000396	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SCARB1—kidney cancer	1.14e-05	0.000391	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000387	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—FH—kidney cancer	1.12e-05	0.000384	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—APRT—kidney cancer	1.12e-05	0.000384	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PSMD7—kidney cancer	1.11e-05	0.000379	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ABCB1—kidney cancer	1.09e-05	0.000375	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF2—kidney cancer	1.09e-05	0.000374	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	1.09e-05	0.000373	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTM1—kidney cancer	1.06e-05	0.000364	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1R—kidney cancer	1.06e-05	0.000362	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GPC3—kidney cancer	1.05e-05	0.000361	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—BCHE—kidney cancer	1.05e-05	0.000359	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.04e-05	0.000355	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CA2—kidney cancer	1.02e-05	0.000351	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—RAF1—kidney cancer	1.02e-05	0.000349	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.01e-05	0.000345	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2—kidney cancer	1e-05	0.000344	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC2A1—kidney cancer	1e-05	0.000343	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ALAD—kidney cancer	9.98e-06	0.000342	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.74e-06	0.000334	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.52e-06	0.000326	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.51e-06	0.000326	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PGK1—kidney cancer	9.13e-06	0.000313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.13e-06	0.000313	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2—kidney cancer	9.12e-06	0.000313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LDHB—kidney cancer	8.95e-06	0.000307	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HIF1A—kidney cancer	8.69e-06	0.000298	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSC2—kidney cancer	8.67e-06	0.000297	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—POMC—kidney cancer	8.63e-06	0.000296	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—kidney cancer	8.34e-06	0.000286	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KDR—kidney cancer	8.31e-06	0.000285	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ABCB1—kidney cancer	7.89e-06	0.000271	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CA9—kidney cancer	7.76e-06	0.000266	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTM1—kidney cancer	7.66e-06	0.000263	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APC—kidney cancer	7.65e-06	0.000262	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KIT—kidney cancer	7.65e-06	0.000262	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—POMC—kidney cancer	7.49e-06	0.000257	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	7.33e-06	0.000251	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—POMC—kidney cancer	7.29e-06	0.00025	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP1A1—kidney cancer	7.27e-06	0.000249	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—BRAF—kidney cancer	7.19e-06	0.000247	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	6.98e-06	0.000239	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—kidney cancer	6.88e-06	0.000236	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	6.67e-06	0.000229	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CRABP1—kidney cancer	6.6e-06	0.000226	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KRAS—kidney cancer	6.59e-06	0.000226	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ITPR2—kidney cancer	6.13e-06	0.00021	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	6.05e-06	0.000208	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RAF1—kidney cancer	6.01e-06	0.000206	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTEN—kidney cancer	6e-06	0.000206	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RELA—kidney cancer	5.98e-06	0.000205	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—kidney cancer	5.98e-06	0.000205	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB2—kidney cancer	5.94e-06	0.000204	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MTOR—kidney cancer	5.87e-06	0.000201	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTT1—kidney cancer	5.59e-06	0.000192	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACHE—kidney cancer	5.59e-06	0.000192	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	5.5e-06	0.000189	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—POMC—kidney cancer	5.42e-06	0.000186	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2—kidney cancer	5.39e-06	0.000185	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SCARB1—kidney cancer	5.3e-06	0.000182	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCND1—kidney cancer	5.25e-06	0.00018	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS1—kidney cancer	5.24e-06	0.00018	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—JUN—kidney cancer	5.24e-06	0.00018	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTEN—kidney cancer	5.21e-06	0.000179	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	5.2e-06	0.000178	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PSMD7—kidney cancer	5.14e-06	0.000176	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTEN—kidney cancer	5.07e-06	0.000174	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—BCHE—kidney cancer	4.87e-06	0.000167	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.81e-06	0.000165	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.65e-06	0.000159	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VEGFA—kidney cancer	4.58e-06	0.000157	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAPK3—kidney cancer	4.33e-06	0.000148	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—kidney cancer	4.32e-06	0.000148	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CA—kidney cancer	4.23e-06	0.000145	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MYC—kidney cancer	4.21e-06	0.000144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAPK1—kidney cancer	4.12e-06	0.000141	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KRAS—kidney cancer	3.89e-06	0.000133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—kidney cancer	3.88e-06	0.000133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTEN—kidney cancer	3.77e-06	0.000129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CA—kidney cancer	3.68e-06	0.000126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ABCB1—kidney cancer	3.67e-06	0.000126	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	3.58e-06	0.000123	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTM1—kidney cancer	3.56e-06	0.000122	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—kidney cancer	3.46e-06	0.000119	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.38e-06	0.000116	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.66e-06	9.12e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—POMC—kidney cancer	2.52e-06	8.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—kidney cancer	2.01e-06	6.89e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTEN—kidney cancer	1.75e-06	6.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.24e-06	4.24e-05	CbGpPWpGaD
